Showing results (91-100 of 129) with videos related to
Sort By:
Pageof 13
Plos One|June 2, 2018
Enhanced survival following oral and systemic Salmonella enterica serovar Typhimurium infection in polymeric immunoglobulin receptor knockout miceKristina J Betz, Elizabeth A Maier, Surya Amarachintha, et al.Vaccine|March 22, 2002
The level of protection against rotavirus shedding in mice following immunization with a chimeric VP6 protein is dependent on the route and the coadministered adjuvantAnthony H Choi, Monica M McNeal, Jason A Flint, et al.Journal of the Pediatric Infectious Diseases Society|September 4, 2015
Safety and Immunogenicity of Full-Dose Trivalent Inactivated Influenza Vaccine (TIV) Compared With Half-Dose TIV Administered to Children 6 Through 35 Months of AgeNatasha B Halasa, Michael A Gerber, Andrea A Berry, et al.Journal of the American Heart Association|March 18, 2022
Operational and Ethical Considerations for a National Adult Congenital Heart Disease DatabaseElisa A Bradley, Abigail Khan, Demetria M McNeal, et al.Journal of Virology|April 28, 2006
Mice develop effective but delayed protective immune responses when immunized as neonates either intranasally with nonliving VP6/LT(R192G) or orally with live rhesus rotavirus vaccine candidatesJohn L VanCott, Anne E Prada, Monica M McNeal, et al.Vaccines|March 19, 2020
Baseline Levels of Influenza-Specific B Cells and T Cell Responses Modulate Human Immune Responses to Swine Variant Influenza A/H3N2 VaccineLilin Lai, Nadine Rouphael, Yongxian Xu, et al.Vaccine|December 15, 2015
Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: A randomized clinical trialDavid I Bernstein, Flor M Munoz, S Todd Callahan, et al.The Journal of Infectious Diseases|February 5, 2015
Safety and Immunogenicity of a Subvirion Monovalent Unadjuvanted Inactivated Influenza A(H3N2) Variant Vaccine in Healthy Persons ≥18 Years OldWendy A Keitel, Lisa A Jackson, Srilatha Edupuganti, et al.AIDS (London, England)|September 24, 2016
Safety and immunogenicity of a live attenuated pentavalent rotavirus vaccine in HIV-exposed infants with or without HIV infection in AfricaMyron J Levin, Jane C Lindsey, Susan S Kaplan, et al.Journal of General Internal Medicine|June 20, 2023
Engaging Operational Partners Is Critical for Successful Implementation of Research Products: a Coincidence Analysis of Access-Related Projects in the Veterans Affairs Healthcare SystemJessica R Dodge, Bradley Youles, Jennifer Caldararo, et al.Pageof 13